(Q62104829)
Statements
BENEFIT-EXT (English)
0 references
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial - Extended Criteria Donors (BENEFIT-EXT) (English)
0 references
February 2005
0 references
May 2008
0 references
595
0 references